Can a simple patch stop diabetes device skin woes?

NCT ID NCT07767461

NEW Recruiting now Disease control Sponsor: Steno Diabetes Center Copenhagen Source: ClinicalTrials.gov ↗

First seen Aug 17, 2026 · Last updated Aug 17, 2026

Summary

This trial tests whether a silicone-based or a hydrocolloid patch placed under insulin pumps or glucose monitors can prevent contact dermatitis from coming back in children aged 2-18. Participants will use different patches and attend visits for skin exams, ultrasounds, and questionnaires. The goal is to find a better way to protect skin so that skin reactions don't stop anyone from getting the diabetes treatment they need.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Silicone-based patch (Hypafix) and hydrocolloid patch (Weloa Sensipatch) used under diabetes devices
What this could lead to: If one patch type works better, it could offer a simple way to prevent skin irritation and help more children with diabetes use their devices comfortably.
What could go wrong: The trial is small and early, so results may not apply to everyone. Some children might still react to the patches themselves, and the study doesn't test long-term effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CONTACT DERMATITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

contact dermatitis type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CONTACT DERMATITIS TYPE 1 DIABETES MELLITUS

Contacts and locations

Locations

Steno Diabetes Center Copenhagen
RECRUITING

Copenhagen, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.